Newsroom

Sorted by: Latest

-

CFEX Launches Billing Solution to Monetize the Whole AI Stack from Watts to Bits to Tokens

SAN FRANCISCO--(BUSINESS WIRE)--CFEX, Inc., announced today the general availability of its AI Billing Solution to help participants in the AI value chain monetize the whole AI stack — from energy to GPUs to training data to generative models to applications. These participants include data centers, AI factories, cloud service providers, data rights holders, model service providers, and application developers. AI compute resources, training data, models, and applications are scarce assets and c...
-

The RMR Group Fiscal First Quarter 2026 Conference Call Scheduled for Thursday, February 5th

NEWTON, Mass.--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today announced that it will issue a press release containing its fiscal first quarter 2026 financial results after the Nasdaq closes on Wednesday, February 4, 2026. On Thursday, February 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Adam Portnoy, Chief Operating Officer Matt Jordan and Chief Financial Officer and Treasurer Matt Brown will host a conference call to discuss these results. The conference call...
-

Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease

BOSTON & COLUMBUS, Ohio--(BUSINESS WIRE)--Ascidian Therapeutics (“Ascidian”), a biotechnology company seeking to treat human diseases by rewriting RNA, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member of the Ajinomoto Bio-Pharma Services group, today announced a strategic partnership to advance the development and manufacturing of ACDN-01, Ascidian’s lead retinal program for the treatment of Stargardt disease. Through this collaboration, Forge is providing Asci...
-

Blackstone Announces Additional Investment in AIR Control Concepts

NORFOLK, Va.--(BUSINESS WIRE)--Air Control Concepts (“AIR”), the largest commercial HVAC, electrical, and controls platform in North America, announced today that funds managed by Blackstone’s private equity strategy for individual investors (“Blackstone”) have signed and closed the acquisition of Madison Dearborn Partners’ (“MDP”) remaining equity stake in AIR, following Blackstone’s original investment in July 2024. Founder, President and CEO of AIR, Brad Hobbs, and his family will also inves...
-

Quantum to Participate at the Needham Growth Conference on January 15

CENTENNIAL, Colo.--(BUSINESS WIRE)--Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), today announced that Hugues Meyrath, Chief Executive Officer, and Laura Nash, Chief Accounting Officer, will participate virtually at the 28th Annual Needham Growth Conference on Thursday, January 15, 2026. Management will be available to host scheduled conference calls with participating investors throughout the day. Portfolio managers and analysts who would like to request a meeting with manag...
-

Corsera Health Announces $80 Million Series A Financing and Reaches Key Clinical Milestone

BOSTON--(BUSINESS WIRE)--Corsera Health, Inc., a clinical-stage company leading the future of cardiovascular health through prediction and prevention, announced it has raised $80 million in a Series A financing. Forbion and Population Health Partners co-led the oversubscribed Series A which included participation from other leading investors, including Corsera Co-Founder and Co-CEO John Maraganore, Ph.D. In connection with the Series A financing, Marco Boorsma, Ph.D., General Partner at Forbion...
-

Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate

WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, inflammatory, and neurological disorders, today announced the nomination of VENT-04, a first-in-class, allosteric caspase-4/5 inhibitor, as a development candidate. Caspase-4/5 activation is intrinsic to dysbiosis, bacteria-induced IL-18 expression, and pyroptotic cell death, which are all adverse factors in diseases of high unmet...
-

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma compa...
-

Oklo and DOE Partner to Deploy Radioisotope Pilot Facility Supporting Cancer Care and U.S. Medical Supply Chains

SANTA CLARA, Calif.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, announced today that it has signed a U.S. Department of Energy (DOE) Other Transaction Agreement (OTA) to support the design, construction, and operation of a radioisotope pilot plant (“Radioisotope Pilot Facility”) under the DOE Reactor Pilot Program (RPP). Signing the OTA is a major milestone which marks the transition from project selection and planning into active execution under D...
-

ClickShare Launches Its First Wireless Room System Bundles Certified for Microsoft Teams with Sennheiser

KORTRIJK, Belgium--(BUSINESS WIRE)--Barco, a global leader in meeting room technology, today announced the launch of new ClickShare Hub room system bundles, developed in partnership with Sennheiser and officially certified for Microsoft Teams. This certification highlights Barco and Microsoft’s shared commitment to delivering advanced meeting room solutions. As one of the first wireless room systems built on the Microsoft Device Ecosystem Platform (MDEP), the certified bundles pair ClickShare H...